ca.investing.com on MSN4mon
Zoetis lifts full-year guidance amid strength at companion animal unitSince its last quarterly results, Zoetis has been bolstered by the approval of its Apoquel Chewable tablet associated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results